9 Meters Biopharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $42,017,051.

Profit Margin

9 Meters Biopharma, Inc. (NASDAQ:NMTR): Profit margin
2013 3.44M -3.43M -99.74%
2014 11.34M -11.05M -97.48%
2015 8.26M -8.74M -105.75%
2016 4.06M -6.21M -152.84%
2017 1.88M -7.92M -420.87%
2018 0 -24.16M
2019 0 -28.87M
2020 0 -65.54M
2021 0 -36.82M
2022 0 -45.51M

NMTR Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
000001.88M4.06M8.26M11.34M3.44M
Cost of revenue
000001.94M3.32M7.84M11.10M2.83M
Gross profit
00000-64K736K426K234K606K
Operating exp.
Research and development
31.00M21.99M10.93M13.71M7.55M190K270K333K542K709K
Selling and marketing
000001.42M2.42M2.92M3.72M1.51M
Total operating expenses
42.01M31.65M21.45M24.28M18.22M6.60M6.67M6.88M6.91M3.97M
Operating income
-42.01M-36.76M-60.87M-25.54M-18.22M-8.88M-6.67M-6.88M-6.91M-3.97M
Other income (expenses), net
-1.74M-17.48K60.81B-1.50M50K963K557K-1.85M-4.13M540K
Income before tax
-43.76M-36.77M-61.49M-27.04M-24.16M-7.92M-6.21M-8.73M-11.04M-3.43M
Income tax expense
1.74M47.18K4.04M1.82M213.83K1.01M2K2K13K4K
Net income
-45.51M-36.82M-65.54M-28.87M-24.16M-7.92M-6.21M-8.74M-11.05M-3.43M
Earnings per share
Basic EPS
-3.51-3.03-12.41-17.33-19.52-13.33-225.11-330.66-416.15-129.94
Diluted EPS
-3.51-3.03-12.41-17.33-19.52-13.33-225.11-328.98-416.15-129.28
Data sourceData sourceData sourceData sourceData sourceData sourceData source